Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
06/29/2023 | MariaDB plc | | Grant | Ordinary Shares | 182.3k | $0.00 | $0 | | 06/29/2023 |
06/07/2023 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Options (Right to Buy) | 14.6k | $0.83 | $12.1k | | 06/07/2023 |
05/11/2023 | MariaDB plc | | Grant | Ordinary Shares | 48.3k | $0.00 | $0 | | 05/11/2023 |
02/10/2023 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Options (right to buy) | 29k | $1.52 | $44.1k | | 02/10/2023 |
12/16/2022 | Angel Pond Holdings Corp | | Other (disposition) | Class B Ordinary Shares | 6.6M | $0.00 | $0 | See Explanation of Responses | 12/16/2022 |
12/16/2022 | MariaDB plc | | Grant | Ordinary Shares | 2.4M | $0.00 | $0 | | 12/16/2022 |
12/31/2021 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Options (right to buy) | 21.8k | $3.10 | $67.7k | | 12/31/2021 |
11/10/2020 | EKSO BIONICS HOLDINGS, INC. | EKSO | Other (disposition) | Common Stock | 744.6k | $0.00 | $0 | By Puissance Cross-Border Opportunities II LLC | 11/10/2020 |
09/10/2020 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 6.5k | $10.12 | $65.9k | | 09/10/2020 |
07/23/2020 | EKSO BIONICS HOLDINGS, INC. | EKSO | Grant | Common Stock | 7.4k | $0.00 | $0 | | 07/23/2020 |
06/08/2020 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 2.6k | $12.87 | $33.5k | | 06/05/2020 |
06/05/2020 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 5k | $12.72 | $63.4k | | 06/05/2020 |
03/02/2020 | EKSO BIONICS HOLDINGS, INC. | EKSO | Other (disposition) | Common Stock | 8.9M | $0.00 | $0 | By Puissance Cross-Border Opportunities II LLC | 03/02/2020 |
01/16/2020 | EKSO BIONICS HOLDINGS, INC. | EKSO | Grant | Common Stock | 19.4k | $0.45 | $8.8k | | 01/16/2020 |
01/16/2020 | EKSO BIONICS HOLDINGS, INC. | EKSO | Grant | Stock Option (right to buy) | 136.5k | $0.38 | $51.9k | | 01/16/2020 |
11/25/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 7.2k | $0.39 | $2.8k | | 11/21/2019 |
11/22/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 1k | $0.37 | $393.5 | | 11/21/2019 |
11/21/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 200 | $0.37 | $74 | | 11/21/2019 |
09/26/2019 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 46.3k | $0.50 | $23.1k | | 09/26/2019 |
06/12/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 50k | $0.64 | $31.9k | | 06/12/2019 |
05/22/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 27.5k | $0.60 | $16.5k | | 05/22/2019 |
05/21/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 43.3k | $0.61 | $26.4k | | 05/21/2019 |
01/25/2019 | Bellerophon Therapeutics, Inc. | BLPH | Purchase | Common Stock | 450k | $0.70 | $315k | | 01/25/2019 |
01/02/2019 | ViewRay, Inc. | VRAY | Grant | Common Stock | 7.3k | $6.16 | $45k | | 01/02/2019 |
01/02/2019 | ViewRay, Inc. | VRAY | Grant | Common Stock | 18.7k | $0.00 | $0 | | 01/02/2019 |
12/21/2018 | ViewRay, Inc. | VRAY | Grant | Stock Option (right to buy) | 19.1k | $5.21 | $99.6k | | 12/21/2018 |
08/03/2018 | EKSO BIONICS HOLDINGS, INC. | EKSO | Grant | Employee Stock Option (right to buy) | 41k | $1.79 | $73.4k | | 08/03/2018 |
08/03/2018 | EKSO BIONICS HOLDINGS, INC. | EKSO | Grant | Common Stock | 19.2k | $1.79 | $34.3k | | 08/03/2018 |
08/02/2018 | ViewRay, Inc. | VRAY | Grant | Common Stock | 1.9k | $8.18 | $15.8k | | 08/02/2018 |
07/02/2018 | ViewRay, Inc. | VRAY | Grant | Common Stock | 2.8k | $7.12 | $20k | | 07/02/2018 |
06/21/2018 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Common Stock | 13.7k | $0.00 | $0 | | 06/21/2018 |
06/13/2018 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 15k | $2.70 | $40.5k | | 06/13/2018 |
06/05/2018 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 38.2k | $2.27 | $86.8k | | 06/05/2018 |
04/06/2018 | Tracon Pharmaceuticals, Inc. | TCON | Grant | Director Stock Option (Right to Buy) | 25k | $2.55 | $63.8k | | 04/06/2018 |
12/12/2017 | Bellerophon Therapeutics, Inc. | BLPH | Grant | Stock Option (right to buy) | 25k | $2.25 | $56.2k | | 12/12/2017 |
|